Pritesh Shah - 07 Nov 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Growth Officer
Signature
Steven Robbins, as attorney in fact for Pritesh, Shah
Issuer symbol
NVCR
Transactions as of
07 Nov 2023
Net transactions value
-$4,832
Form type
4
Filing time
08 Nov 2023, 16:22:37 UTC
Previous filing
05 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale $4,832 -382 -0.31% $12.65 124,511 07 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.